b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31351496</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>09</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1756-9966</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>38</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Jul</Month>\n                        <Day>27</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of experimental &amp; clinical cancer research : CR</Title>\n                <ISOAbbreviation>J. Exp. Clin. Cancer Res.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>RNA helicase p68 deploys \xce\xb2-catenin in regulating RelA/p65 gene expression: implications in colon cancer.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>330</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13046-019-1304-y</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">RelA/p65 a crucial member of NF-\xce\xbaB signaling pathway plays diverse role in mediating oncogenesis. Limited knowledge prevails on the mechanistic insights of RelA gene regulation. RNA helicase p68 apart from being a vital player of RNA metabolism acts as a transcriptional coactivator of several oncogenic transcription factors including \xce\xb2-catenin and is highly implicated in cancer progression. In this study, we aim to discern the molecular mechanism of how an RNA helicase, p68 deploys a major oncogenic signaling pathway, Wnt/ \xce\xb2-catenin to regulate the expression of RelA, an indispensable component of NF-\xce\xbaB signaling pathway towards driving colon carcinogenesis.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">Immunoblotting and quantitative RT-PCR was performed for determining the protein and mRNA expressions of the concerned genes respectively. Luciferase assay was employed for studying the promoter activity of RelA. Chromatin immunoprecipitation was used to evaluate the occupancy of transcription factors on the RelA promoter. Immunohistochemical analysis was conducted using FFPE sections derived from normal human colon and colon cancer patient samples. Finally, a syngeneic colorectal allograft mouse model was used to assess physiological significance of the in vitro findings.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">p68, \xce\xb2-catenin and RelA proteins were found to bear strong positive correlation in normal and colon carcinoma patient samples. Both p68 and \xce\xb2-catenin increased RelA mRNA and protein expression. p68, \xce\xb2-catenin and Wnt3a elevated RelA promoter activity. Conversely, p68 and \xce\xb2-catenin knockdown diminished RelA promoter activity and led to reduced RelA mRNA and protein expression. p68 was perceived to occupy RelA promoter with \xce\xb2-catenin at the TCF4/LEF (TBE) sites thereby potentiating RelA transcription. p68 and \xce\xb2-catenin alliance positively modulated the expression of signature NF-\xce\xbaB target genes. Enhanced NF-\xce\xbaB target gene expression by p68 was corroborated by findings in clinical samples. Tumors generated in mice colorectal allograft model, stably expressing p68 further reinforced our in vitro findings.</AbstractText>\n                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We report for the first time a novel mechanism of alliance between p68 and \xce\xb2-catenin in regulating the expression of RelA and stimulating the NF-\xce\xbaB signaling axis towards driving colon carcinogenesis. This study unravels novel modes of p68-mediated colon carcinogenesis, marking it a potential target for therapy.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Khare</LastName>\n                    <ForeName>Veenita</ForeName>\n                    <Initials>V</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TRUE Campus, CN-6, Sector-V, Salt Lake, Kolkata- 700091 &amp; 4, Raja S.C. Mullick Road, Jadavpur, Kolkata, 700032, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tabassum</LastName>\n                    <ForeName>Shaheda</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TRUE Campus, CN-6, Sector-V, Salt Lake, Kolkata- 700091 &amp; 4, Raja S.C. Mullick Road, Jadavpur, Kolkata, 700032, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chatterjee</LastName>\n                    <ForeName>Uttara</ForeName>\n                    <Initials>U</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pathology, Park Clinic, 4, Gorky Terrace, Kolkata, 700017, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chatterjee</LastName>\n                    <ForeName>Sandip</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pathology, Park Clinic, 4, Gorky Terrace, Kolkata, 700017, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ghosh</LastName>\n                    <ForeName>Mrinal K</ForeName>\n                    <Initials>MK</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TRUE Campus, CN-6, Sector-V, Salt Lake, Kolkata- 700091 &amp; 4, Raja S.C. Mullick Road, Jadavpur, Kolkata, 700032, India. mrinal.res@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>EMR-2017-000992</GrantID>\n                    <Agency>DST-SERB</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>27</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>J Exp Clin Cancer Res</MedlineTA>\n            <NlmUniqueID>8308647</NlmUniqueID>\n            <ISSNLinking>0392-9078</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C498143">RELA protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D051996">Transcription Factor RelA</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D051176">beta Catenin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.6.4.13</RegistryNumber>\n                <NameOfSubstance UI="D053487">DEAD-box RNA Helicases</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D053487" MajorTopicYN="N">DEAD-box RNA Helicases</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015972" MajorTopicYN="Y">Gene Expression Regulation, Neoplastic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D064593" MajorTopicYN="N">Heterografts</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020218" MajorTopicYN="N">Response Elements</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051996" MajorTopicYN="N">Transcription Factor RelA</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051176" MajorTopicYN="N">beta Catenin</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Colorectal cancer</Keyword>\n            <Keyword MajorTopicYN="N">Murine model</Keyword>\n            <Keyword MajorTopicYN="N">NF-\xce\xbaB signaling cascade</Keyword>\n            <Keyword MajorTopicYN="N">RNA helicase p68</Keyword>\n            <Keyword MajorTopicYN="N">RelA gene regulation</Keyword>\n            <Keyword MajorTopicYN="N">Wnt/\xce\xb2-catenin signaling</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>03</Month>\n                <Day>12</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>29</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>29</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>10</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31351496</ArticleId>\n            <ArticleId IdType="doi">10.1186/s13046-019-1304-y</ArticleId>\n            <ArticleId IdType="pii">10.1186/s13046-019-1304-y</ArticleId>\n            <ArticleId IdType="pmc">PMC6660689</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Nature. 1999 Apr 1;398(6726):422-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10201372</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurochem. 2000 Oct;75(4):1377-89</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10987817</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2000 Oct 13;103(2):311-20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11057903</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2001 Nov 1;20(50):7342-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11704864</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncology. 2003;65(1):37-45</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12837981</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2003 Jul 19;362(9379):205-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12885482</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cell. 2003 Jul;12(1):255-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12887910</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2005 Jul 20;115(6):967-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15729715</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Immunol. 2005 Oct;5(10):749-59</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16175180</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2005 Nov 1;11(21):7621-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16278380</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2007 Aug 15;67(16):7572-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17699760</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2008 Oct 27;27(50):6398-406</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18955968</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cell Biochem. 2010 Mar;336(1-2):25-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19823771</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Virol. 2010 Apr;84(8):4050-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20089639</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Opin Ther Targets. 2010 Jun;14(6):593-601</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20367537</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>For Immunopathol Dis Therap. 2010;1(3):155-181</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21686046</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2012 Jan 19;12(2):121-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22257950</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biol Chem. 2012 May 25;287(22):18287-96</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22493441</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Med Chem. 2012;19(22):3679-88</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22680927</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neuro Oncol. 2012 Sep;14(9):1116-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22810421</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Opin Ther Targets. 2013 Jan;17(1):61-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23173842</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Mol Med (Berl). 2013 Sep;91(9):1029-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23636511</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2014 Oct 15;135(8):1800-11</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24623448</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Exp Clin Cancer Res. 2014 Aug 24;33:64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25150365</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Death Differ. 2015 Feb;22(2):298-310</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25257174</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Ther. 2015 Feb;23(2):255-69</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25327178</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Oncol (Dordr). 2015 Aug;38(4):265-77</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25925205</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Biosci (Landmark Ed). 2016 Jan 01;21:225-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26709771</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Signal. 2016 Jun;28(6):675-87</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27012497</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Virol. 1995 Sep;69(9):5391-400</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7636984</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Acquir Immune Defic Syndr. 1993 Mar;6(3):227-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8450395</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Exp Med. 1998 Jul 6;188(1):211-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9653098</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 1998 Sep 4;281(5382):1509-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9727977</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'